Single Cell Analysis

News

Research into single-cell sequencing has been boosted with Single Cell Discoveries and BioTuring joining forces to refine the process.

Partner Content

Partner Content

2 days, 350+ end users, 80+ case studies

News

Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.